awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26825636-0560DBC2-6093-4CE9-9032-47170C67BC4C
Q26825636-0560DBC2-6093-4CE9-9032-47170C67BC4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26825636-0560DBC2-6093-4CE9-9032-47170C67BC4C
Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials
P2860
Q26825636-0560DBC2-6093-4CE9-9032-47170C67BC4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26825636-0560DBC2-6093-4CE9-9032-47170C67BC4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ccc2818dae96777c47b9ea79133f01bb248079c1
P2860
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial